919 related articles for article (PubMed ID: 31709936)
1. [Comparison of Tuberculin Skin Test (TST) and T-SPOT.TB Tests for Diagnosis of Latent Tuberculosis Infection (LTBI) in HIV-infected Patients].
Binay UD; Fincancı M; Fersan E; Karakeçili F
Mikrobiyol Bul; 2019 Oct; 53(4):388-400. PubMed ID: 31709936
[TBL] [Abstract][Full Text] [Related]
2. Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia.
Chkhartishvili N; Kempker RR; Dvali N; Abashidze L; Sharavdze L; Gabunia P; Blumberg HM; Del Rio C; Tsertsvadze T
BMC Infect Dis; 2013 Nov; 13():513. PubMed ID: 24176032
[TBL] [Abstract][Full Text] [Related]
3. IFN-γ response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection.
Latorre I; Martínez-Lacasa X; Font R; Lacoma A; Puig J; Tural C; Lite J; Prat C; Cuchi E; Ausina V; Domínguez J
BMC Infect Dis; 2010 Dec; 10():348. PubMed ID: 21143955
[TBL] [Abstract][Full Text] [Related]
4. Good Agreement between an Interferon Gamma Release Assay and Tuberculin Skin Tests in Testing for Latent Tuberculosis Infection among HIV-Infected Patients in Indonesia.
Reviono R; Saptawati L; Redhono D; Suryawati B
J Korean Med Sci; 2019 Oct; 34(40):e259. PubMed ID: 31625291
[TBL] [Abstract][Full Text] [Related]
5. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
[TBL] [Abstract][Full Text] [Related]
6. Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test.
Ramos JM; Robledano C; Masiá M; Belda S; Padilla S; Rodríguez JC; Gutierrez F
BMC Infect Dis; 2012 Jul; 12():169. PubMed ID: 22849726
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
8. HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study.
Pullar ND; Steinum H; Bruun JN; Dyrhol-Riise AM
BMC Infect Dis; 2014 Dec; 14():667. PubMed ID: 25515915
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two interferon-gamma release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB) in testing for latent tuberculosis infection among HIV-infected adults.
Sultan B; Benn P; Mahungu T; Young M; Mercey D; Morris-Jones S; Miller RF
Int J STD AIDS; 2013 Oct; 24(10):775-9. PubMed ID: 23970606
[TBL] [Abstract][Full Text] [Related]
10. Poor agreement between diagnostic tests for latent tuberculosis infection among HIV-infected persons in Hong Kong.
Leung CC; Chan K; Yam WC; Lee MP; Chan CK; Wong KH; Ho PL; Mak I; Tam CM
Respirology; 2016 Oct; 21(7):1322-9. PubMed ID: 27121551
[TBL] [Abstract][Full Text] [Related]
11. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results.
Costantino F; de Carvalho Bittencourt M; Rat AC; Loeuille D; Dintinger H; Béné MC; Faure G; Chary-Valckenaere I
J Rheumatol; 2013 Dec; 40(12):1986-93. PubMed ID: 24085550
[TBL] [Abstract][Full Text] [Related]
12. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
O'Shea MK; Fletcher TE; Beeching NJ; Dedicoat M; Spence D; McShane H; Cunningham AF; Wilson D
PLoS One; 2014; 9(5):e97366. PubMed ID: 24816576
[TBL] [Abstract][Full Text] [Related]
13. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country.
Stephan C; Wolf T; Goetsch U; Bellinger O; Nisius G; Oremek G; Rakus Z; Gottschalk R; Stark S; Brodt HR; Staszewski S
AIDS; 2008 Nov; 22(18):2471-9. PubMed ID: 19005270
[TBL] [Abstract][Full Text] [Related]
14. TST, QuantiFERON-TB Gold test and T-SPOT.TB test for detecting latent tuberculosis infection in patients with rheumatic disease prior to anti-TNF therapy.
Sargın G; Şentürk T; Ceylan E; Telli M; Çildağ S; Doğan H
Tuberk Toraks; 2018 Jun; 66(2):136-143. PubMed ID: 30246657
[TBL] [Abstract][Full Text] [Related]
15. Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection.
Elzi L; Steffen I; Furrer H; Fehr J; Cavassini M; Hirschel B; Hoffmann M; Bernasconi E; Bassetti S; Battegay M
BMC Infect Dis; 2011 Nov; 11():319. PubMed ID: 22085801
[TBL] [Abstract][Full Text] [Related]
16. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
[TBL] [Abstract][Full Text] [Related]
17. Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test?
Soysal A; Toprak D; Koc M; Arikan H; Akoglu E; Bakir M
Nephrol Dial Transplant; 2012 Apr; 27(4):1645-50. PubMed ID: 21931124
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of latent tuberculosis among HIV infected patients in Ilorin, Nigeria using tuberculin skin test and interferon gamma release assay.
Aladesanmi AO; Ojuawo OB; Aladesanmi OO; Fawibe AE; Desalu OO; Ojuawo AB; Opeyemi CM; Adio MO; Oluwaloniola V; Salami AK
Pan Afr Med J; 2021; 38():24. PubMed ID: 33777292
[TBL] [Abstract][Full Text] [Related]
19. Combined use of a TST and the T-SPOT®.TB assay for latent tuberculosis infection diagnosis before anti-TNF-α treatment.
Jung YJ; Lyu J; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee KH; Lee SD; Kim WS; Kim DS; Shim TS
Int J Tuberc Lung Dis; 2012 Oct; 16(10):1300-6. PubMed ID: 22863375
[TBL] [Abstract][Full Text] [Related]
20. Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden country.
Cheallaigh CN; Fitzgerald I; Grace J; Singh GJ; El-Eraki N; Gibbons N; Keane J; Rogers TR; Clarke S; Bergin C
PLoS One; 2013; 8(1):e53330. PubMed ID: 23382842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
